Phase 2 Study of DKN-01 in Colorectal Cancer

Clinical trial NCT05480306 · COMPLETED

Trial details

NCT number: NCT05480306
Sponsor: Leap Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Colorectal Adenocarcinoma Colo-rectal Cancer Colorectal Cancer Metastatic

Start date: 2022-08-30
Primary completion: 2025-07-10
Enrollment: 188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.